Parma Radosław, Zembala Michał O, Dąbrowski Maciej, Jagielak Dariusz, Witkowski Adam, Suwalski Piotr, Dudek Dariusz, Olszówka Piotr, Wojakowski Wojciech, Przybylski Roman, Gil Robert, Kuśmierczyk Mariusz, Lesiak Maciej, Sadowski Jerzy, Dobrzycki Sławomir, Ochała Andrzej, Hoffman Piotr, Kapelak Bogusław, Kaźmierczak Jarosław, Jasiński Marek, Stępińska Janina, Szymański Piotr, Hryniewiecki Tomasz, Kochman Janusz, Grygier Marek, Zembala Marian, Legutko Jacek, Różański Jacek
2nd Department of Cardiology, Jagiellonian University Medical College, Krakow, Poland.
Kardiol Pol. 2017;75(9):937-964. doi: 10.5603/KP.2017.0175.
Patients with severe symptomatic aortic stenosis have a poor prognosis with medical management alone, and surgical aortic valve replacement can improve symptoms and survival. In recent years, transcatheter aortic valve implantation (TAVI) has been demonstrated to improve survival in inoperable patients and to be an alternative treatment in patients in whom the risk of surgical morbidity or mortality is high or intermediate. A representative expert committee, summoned by the Association of Cardiovascular Interventions of the Polish Cardiac Society (ACVI) and the Polish Society of Cardio-Thoracic Surgeons, devel-oped this Consensus Statement in transcatheter aortic valve implantation. It endorses the important role of a multi-disciplinary "TAVI team" in selecting patients for TAVI and defines operator and institutional requirements fundamental to the establish-ment of a successful TAVI programme. The article summarises current evidence and provides specific recommendations on organisation and conduct of transcatheter treatment of patients with aortic valve disease in Poland.
重度症状性主动脉瓣狭窄患者仅接受药物治疗时预后较差,而外科主动脉瓣置换术可改善症状并提高生存率。近年来,经导管主动脉瓣植入术(TAVI)已被证明可提高无法手术患者的生存率,并可作为手术并发症或死亡率风险高或中等的患者的替代治疗方法。由波兰心脏学会心血管介入协会(ACVI)和波兰心胸外科学会召集的一个具有代表性的专家委员会制定了这份经导管主动脉瓣植入术共识声明。它认可多学科“TAVI团队”在选择TAVI患者方面的重要作用,并定义了成功开展TAVI项目所需的操作者和机构要求。本文总结了当前证据,并就波兰主动脉瓣疾病患者经导管治疗的组织和实施提供了具体建议。